文献速递儿科与产科急症呼吸衰竭与机械通气消化、代谢与肾脏急症

以色列青少年SARS-CoV-2感染患者的分诊表现

Triage performance in adolescent patients with SARS-CoV-2 infection in Israel.
PubMed 文献 · Am J Emerg Med · 2022-07-02
一句话结论在12-18岁SARS-CoV-2感染青少年中,PaedCTAS 1-2级与住院和ICU入住风险显著升高独立相关。

该研究在以色列17家公立医院急诊科前瞻性纳入2021年6月11日至8月15日Delta变异株流行期间12-18岁SARS-CoV-2感染患者305例,其中267例(87.5%)未接种疫苗。67例(22.0%)入住儿科病房,12例(3.9%)入住ICU。多因素回归显示,PaedCTAS 1-2级(aOR 5.74,95%CI 2.30-14.35,p<0.0001)和慢性病(aOR 2.9,95%CI 1.48-5.67,p<0.02)与住院风险升高独立相关;PaedCTAS 1-2级(aOR 27.79,95%CI 3.85-176.91,p<0.001)和就诊时呼吸系统症状(aOR 26.10,95%CI 4.47-172.63,p<0.0001)与ICU入住风险升高独立相关。离院患者中217/226(96%)为PaedCTAS 3-5级。作者认为PaedCTAS在该队列中表现良好。

要点

  • 12-18岁SARS-CoV-2感染者中,PaedCTAS 1-2级与住院风险升高独立相关(aOR 5.74,95%CI 2.30-14.35,p<0.0001)。
  • PaedCTAS 1-2级与ICU入住风险升高独立相关(aOR 27.79,95%CI 3.85-176.91,p<0.001),为最强相关因素。
  • 就诊时呼吸系统症状与ICU入住风险升高独立相关(aOR 26.10,95%CI 4.47-172.63,p<0.0001)。
  • 慢性病与住院风险升高独立相关(aOR 2.9,95%CI 1.48-5.67,p<0.02)。
  • 离院患者中96%(217/226)为PaedCTAS 3-5级,作者认为PaedCTAS在该队列中表现良好。

适用人群与场景

  • 2021年6月11日至8月15日Delta变异株流行期间,以色列17家公立医院急诊科就诊的12-18岁SARS-CoV-2感染患者305例,其中267例(87.5%)未接种疫苗。

诊断标准与关键阈值

  • 分诊采用儿科加拿大分诊与严重度量表(PaedCTAS),级别1-2级定义为高危,3-5级定义为低危。

红旗征与不能漏的情况

  • PaedCTAS 1-2级与住院(aOR 5.74,95%CI 2.30-14.35,p<0.0001)和ICU入住(aOR 27.79,95%CI 3.85-176.91,p<0.001)风险升高独立相关。
  • 就诊时呼吸系统症状与ICU入住风险升高独立相关(aOR 26.10,95%CI 4.47-172.63,p<0.0001)。
  • 慢性病与住院风险升高独立相关(aOR 2.9,95%CI 1.48-5.67,p<0.02)。

研究设计与关键结果

  • 研究类型为时间序列研究,在以色列17家公立医院急诊科前瞻性收集2021年6月11日至8月15日Delta变异株流行期间数据,纳入305例12-18岁SARS-CoV-2感染患者,其中267例(87.5%)未接种疫苗。
  • 67例(22.0%)入住儿科病房,12例(3.9%)入住ICU;离院患者中217/226(96%)为PaedCTAS 3-5级。
  • 多因素回归显示,PaedCTAS 1-2级与住院风险升高独立相关(aOR 5.74,95%CI 2.30-14.35,p<0.0001),慢性病与住院风险升高独立相关(aOR 2.9,95%CI 1.48-5.67,p<0.02)。
  • PaedCTAS 1-2级与ICU入住风险升高独立相关(aOR 27.79,95%CI 3.85-176.91,p<0.001),就诊时呼吸系统症状与ICU入住风险升高独立相关(aOR 26.10,95%CI 4.47-172.63,p<0.0001)。

证据类型、等级与局限

  • 证据类型:时间序列研究(前瞻性数据收集),多因素回归分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为PaedCTAS在该12-18岁SARS-CoV-2感染队列中表现良好;PaedCTAS 1-2级是与住院和ICU入住相关的最强因素,几乎所有离院患者均为PaedCTAS 3-5级。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: The aim of this study was to assess the performance of the Pediatric Canadian Triage and Acuity Scale (PaedCTAS) in adolescent patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.

METHODS: A time-series study was conducted in the Emergency Departments (EDs) of 17 public hospitals during the Delta (B.1.617.2) variant spread in Israel. Data were collected prospectively from June 11, 2021 to August 15, 2021. Multivariate regression analyses were performed to identify independent variables associated with hospital admission and with admission to an Intensive Care Unit (ICU).

RESULTS: During the study period, 305 SARS-CoV-2 patients ages 12-18 years presenting to the ED were included, and 267 (87.5%) were unvaccinated. Sixty-seven (22.0%) and 12 (3.9%) patients were admitted to pediatric wards and ICUs, respectively. PaedCTAS level 1-2 and the presence of chronic disease increased the odds of hospital admission (adjusted odds ratio (aOR) 5.74, 95% CI, 2.30-14.35, p < 0.0001), and (aOR 2.9, 95% CI, 1.48-5.67, p < 0.02), respectively. PaedCTAS level 1-2 and respiratory symptoms on presentation to ED increased the odds of ICU admission (aOR 27.79; 95% CI, 3.85-176.91, p < 0.001), and (aOR 26.10; 95% CI, 4.47-172.63, p < 0.0001), respectively. PaedCTAS level 3-5 was found in 217/226 (96%) of the patients who were discharged home from the ED.

CONCLUSIONS: The findings suggest that PaedCTAS level 1-2 was the strongest factor associated with hospital and ICU admission. Almost all the patients who were discharged home had PaedCTAS level 3-5. Study findings suggest good performance of the PaedCTAS in this cohort.

来源:Am J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Levy N, Friedman N, Kaplan O, et al. Triage performance in adolescent patients with SARS-CoV-2 infection in Israel. Am J Emerg Med. 2022. PMID: 35803040. doi:10.1016/j.ajem.2022.06.061

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。